CD8A and non-small cell lung carcinoma: Consistently, immune composition data indicate that patients with high tumoral FXR and HVEM expression levels (FXRhiHVEMhi) had the lowest number of infiltrating CD8+ T cells and the highest number of infiltrating MDSCs and TAMs among all NSCLC subgroups (Figure 5, H–J).